Gilead Sciences (GILD) Deferred Taxes (2016 - 2025)
Gilead Sciences (GILD) has disclosed Deferred Taxes for 17 consecutive years, with -$122.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Deferred Taxes rose 67.81% year-over-year to -$122.0 million, compared with a TTM value of $160.0 million through Dec 2025, up 108.68%, and an annual FY2025 reading of $160.0 million, up 108.68% over the prior year.
- Deferred Taxes was -$122.0 million for Q4 2025 at Gilead Sciences, down from $659.0 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $659.0 million in Q3 2025 and bottomed at -$723.0 million in Q1 2024.
- Average Deferred Taxes over 5 years is -$215.7 million, with a median of -$245.5 million recorded in 2022.
- The sharpest move saw Deferred Taxes skyrocketed 298.35% in 2021, then tumbled 1016.9% in 2022.
- Year by year, Deferred Taxes stood at -$359.0 million in 2021, then rose by 5.85% to -$338.0 million in 2022, then decreased by 9.47% to -$370.0 million in 2023, then fell by 2.43% to -$379.0 million in 2024, then surged by 67.81% to -$122.0 million in 2025.
- Business Quant data shows Deferred Taxes for GILD at -$122.0 million in Q4 2025, $659.0 million in Q3 2025, and -$178.0 million in Q2 2025.